Russell Investments Group Ltd. lowered its holdings in shares of Endo International PLC (NASDAQ:ENDP) (TSE:ENL) by 19.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 83,979 shares of the company’s stock after selling 20,176 shares during the quarter. Russell Investments Group Ltd.’s holdings in Endo International were worth $1,412,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. United Services Automobile Association raised its holdings in shares of Endo International by 16.7% during the 2nd quarter. United Services Automobile Association now owns 41,508 shares of the company’s stock valued at $391,000 after purchasing an additional 5,933 shares in the last quarter. Diamond Hill Capital Management Inc. raised its holdings in Endo International by 1.0% in the 2nd quarter. Diamond Hill Capital Management Inc. now owns 1,100,259 shares of the company’s stock worth $10,375,000 after acquiring an additional 10,600 shares during the period. First Hawaiian Bank bought a new position in Endo International in the 3rd quarter worth $358,000. Nisa Investment Advisors LLC raised its holdings in Endo International by 1,209.0% in the 3rd quarter. Nisa Investment Advisors LLC now owns 26,179 shares of the company’s stock worth $441,000 after acquiring an additional 24,179 shares during the period. Finally, Van ECK Associates Corp raised its holdings in Endo International by 7.2% in the 2nd quarter. Van ECK Associates Corp now owns 368,590 shares of the company’s stock worth $3,476,000 after acquiring an additional 24,693 shares during the period. Institutional investors and hedge funds own 96.63% of the company’s stock.

In other news, Director Nancy J. Hutson sold 10,000 shares of the business’s stock in a transaction dated Thursday, November 15th. The shares were sold at an average price of $12.83, for a total transaction of $128,300.00. Following the transaction, the director now owns 49,970 shares in the company, valued at approximately $641,115.10. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 0.80% of the company’s stock.

NASDAQ:ENDP opened at $11.57 on Friday. Endo International PLC has a 52-week low of $5.27 and a 52-week high of $18.50. The stock has a market cap of $2.60 billion, a PE ratio of 3.99, a P/E/G ratio of 4.25 and a beta of 0.35.

Endo International (NASDAQ:ENDP) (TSE:ENL) last posted its quarterly earnings data on Thursday, November 8th. The company reported $0.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.59 by $0.12. Endo International had a negative net margin of 37.82% and a positive return on equity of 1,348.52%. The company had revenue of $745.00 million for the quarter, compared to the consensus estimate of $694.93 million. During the same quarter in the previous year, the firm posted $0.91 EPS. The business’s revenue was down 5.3% compared to the same quarter last year. On average, equities research analysts forecast that Endo International PLC will post 2.73 earnings per share for the current year.

ENDP has been the topic of several recent analyst reports. Mizuho lifted their target price on shares of Endo International to $17.00 and gave the stock a “neutral” rating in a report on Tuesday, August 14th. TheStreet upgraded shares of Endo International from a “d” rating to a “c-” rating in a report on Monday, August 20th. Zacks Investment Research upgraded shares of Endo International from a “hold” rating to a “buy” rating and set a $18.00 target price on the stock in a report on Monday, September 24th. Cantor Fitzgerald lifted their target price on shares of Endo International from $12.00 to $18.00 and gave the stock a “neutral” rating in a report on Friday, October 19th. Finally, Canaccord Genuity upgraded shares of Endo International from a “hold” rating to a “buy” rating and lifted their target price for the stock from $16.00 to $20.00 in a report on Friday, November 9th. One research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating, six have given a buy rating and two have given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $15.32.

ILLEGAL ACTIVITY NOTICE: This report was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this report on another domain, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this report can be viewed at https://www.dailypolitical.com/2018/12/08/russell-investments-group-ltd-sells-20176-shares-of-endo-international-plc-endp.html.

Endo International Company Profile

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.

Further Reading: What are different types of coverage ratios?

Want to see what other hedge funds are holding ENDP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Endo International PLC (NASDAQ:ENDP) (TSE:ENL).

Institutional Ownership by Quarter for Endo International (NASDAQ:ENDP)

Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.